High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts (Q37807871)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

post-transplant lymphoproliferative disorder

0 references

0 references

author name string

M Hoegh-Petersen

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

D Goodyear

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

M N Geddes

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

S Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

A Ugarte-Torres

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Y Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

J T Walker

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

K Fonseca

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

A Daly

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

P Duggan

10

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

D Stewart

11

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

J A Russell

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

J Storek

13

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1104-1112

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Prevalence of Epstein-Barr virus in Japan: trends and future prediction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Epstein-Barr virus: the impact of scientific advances on clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Treatment of PTLD with rituximab or chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Viral disease prevention after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

21 January 2018

Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Prompt versus preemptive intervention for EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.272

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2010.272

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37807871&oldid=2200968722"